Skip to main content
. 2018 Dec 19;60(2):221–227. doi: 10.1093/jrr/rry089

Table 3.

Multivariate analyses for overall survival, PSA-FFS, Grade ≥2 late GU and GI toxicity

Overall survival PSA-FFS Late GU toxicity Late GI toxicity
Hazard ratio P Hazard ratio P Hazard ratio P Hazard ratio P
Age 2.73 0.02 0.89 0.68 1.90 0.17 1.27 0.49
(≥ vs <70 years) (1.19–6.27) (0.50–1.57) (1.77–4.71) (0.65–2.50)
Risk 1.62 0.26 2.66 0.005 1.09 0.86 1.15 0.71
(HR vs LR/IR) (0.70–3.72) (1.35–5.22) (0.43–2.70) (0.56–2.34)
ADT 3.22 0.13 1.12 0.81 1.32 0.72 4.33 0.15
(Yes vs no) (0.71–14.51) (0.43–2.96) (0.30–5.81) (0.59–32.00)
Anticoagulant 1.66 0.23 0.51 0.13 1.62 0.33 2.03 0.06
(Yes vs no) (0.73–3.81) (0.21–1.22) (0.61–4.26) (0.97–4.24)
Coexistent DM 0.86 0.76 1.43 0.32 1.42 0.49 1.71 0.17
(Yes vs no) (0.32–2.29) (0.71–2.90) (0.52–3.92) (0.80–3.66)

LR, IR, HR = low, intermediate, and high risk, ADT = androgen deprivation therapy, DM = diabetes mellitus.